Back

Validation of the "multivalvular score" for the assessment of patients with concomitant mitral and aortic valve disease under evaluation for transcatheter aortic valve implantation.

27 August 2018 (17:05 - 17:15)
Organised by:
Congress Presentation Part of: Controversies and unmet needs around TAVI Aortic Valve Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Pablo Catala-Ruiz

University Hospital Bellvitge, Barcelona (Spain)

4 More presentations in this session

Presentation thumbnail
Survival and Long-term clinical outocmes after Transcatheter Aortic Valve Replacement in high-risk patients with severe aortic stenosis.
Doctor A. Munoz Garcia (Malaga, ES)
Abstract Slides Video
Presentation thumbnail
Impact of primary hemostasis disorders on late (>30 days) major/life-threatening bleedings after TAVR
Doctor M. Kibler (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Impact of coronary artery disease and PCI on Long-term outcomes of women undergoing transcatheter aortic valve replacement: insights from the multi-center WIN-TAVI registry
Doctor P. Guedeney (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Impact of prosthetic valve regurgitation quantified by cardiac magnetic resonance imaging on long-term mortality after TAVI
Doctor M. Abdelghani (Cairo, EG)
Abstract Slides Video

Access the full session

Session thumbnail
Controversies and unmet needs around TAVI

The Event

Event poster

ESC Congress 2018

27 August 2018 17:05 CET
You may be interested in
thumbnail
Congress Presentation
Aortic regurgitation and stenosis: diagnosis and mode of intervention
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Session
Controversies in heart valve disease: integrating art, science, medicine, and surgery into decision-making

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources